With obesity costing $1.4 trillion annually, Shawn Davis, MD, argues the return on treatment investment is clear if we build systems to measure it. One of the most pressing financial debates in ...

A new systematic review and meta-analysis appearing in the Journal of Sport and Health Science suggests that combining strength and aerobic exercise may offer greater improvements ...

Reflecting on the evolution of bispecific antibodies in multiple myeloma, Ajai Chari, MD, professor of medicine and director of the Multiple Myeloma Program at the University of C ...

Benjamin Lockshin, MD, FAAD, examines how geographic variation in psoriasis patient characteristics and biologic prescribing reflects a complex interplay of insurance access, formulary structure, ...

Benjamin Lockshin, MD, FAAD, outlines the clinical and practical factors driving the dominance of IL-23 inhibitors in biologic initiation, highlighting their favorable safety profile, ease of patient ...

Two-year data confirm DOR/ISL delivers durable viral suppression—even in patients with high viral loads or advanced disease.

Neurologist visit frequency was modestly higher among cancer cases than controls but declined over time in both settings, ...

Global pediatric HIV data show dolutegravir links to early modest weight gain that plateaus by year 2, easing concerns and ...

A study suggests vitamin D may reduce long COVID symptoms at 8 weeks, although larger trials are needed to confirm benefits ...

Capping Medicare beneficiaries’ monthly insulin out-of-pocket costs at $35 was associated with steep reductions in spending ...

Steven Kheloussi, PharmD, explores how smarter clinical tools, multidisciplinary teams, and better care coordination can ...

Metabolic dysfunction-associated steatohepatitis (MASH) places a significant burden on the lives of patients, but a proactive ...